search this site
- home
- highlights
- sinclair at a glance
- growing our operations worldwide
- products:oral health
- products:dermatology
- chairman´s statement
- business review:operational
- business review:financial
- board of directors
- senior management
- directors´ report
- corporate governance report
- directors´ remuneration report
- independent auditors´ report
- consolidated income statement
- balance sheets
- statements of changes in shareholders´ equity
- cash flow statements
- notes to the financial statements
- corporate advisors
Products:
Oral Health
The oral health market is broad, including dental prescription and over-the-counter (OTC) products for gum disease, fresh breath, mouth ulcers and many other conditions. Sinclair competes in the gingivitis and mouth ulcer categories.
Sinclair now has two flagship oral health products and a series of smaller products. Flagship brands are: Decapinol®, for gum disease (gingivitis) and plaque, and Aloclair® for mouth ulcers. Both of these are approved in the US and EU and in some additional territories.
Other products in our oral health portfolio include
SST® and Salinum®, both for xerostomia, and Gelclair® for severe oral lesions. Our pipeline includes a series
of line extensions using the Decapinol® technology
for oral care.
Sinclair´s oral health products are only sold through
marketing partners.
Our key oral health products include:
DECAPINOL®
(rinse, toothpaste, gel, spray)
PRODUCT DESCRIPTION
Decapinol® represents a novel
treatment, containing delmopinol,
for gingivitis (gum disease) and
dental plaque, offering significant
advantages over existing products.
It employs a new mode of action
that interferes with the ability of
the bacteria to adhere to the
surface of the teeth and gums
rather than killing the bacteria.
This enables the maintenance of
a healthy balance of mouth flora.
Sinclair continues to maximise
this unique technology through
line extensions and additional
care products. In addition to the
flagship rinse we have toothpaste
containing fluoride, a spray and
a gel that can be applied directly
to the gum margin in order to
relieve the pain of dental
procedures or tooth cleaning.
STATUS
Approved in the EU and US.
PROGRESS
Decapinol® is sold in six countries:
Italy – Dompé Pharmaceuticals
Israel – Kivema
Finland – Farmakate
Norway – Nycomed
Greece and Cyprus – Arriani.
Launches took place in:
Israel – July 2007
Greece – September 2007
Finland – August 2007
Norway – March 2008.
ALOCLAIR®
(rinse, gel and spray)
PRODUCT DESCRIPTION
A range of products incorporating
´coating’ technology to provide
fast and effective pain relief from
the discomfort of mouth ulcers
and other minor oral lesions.
When sprayed onto the ulcer, a
barrier is formed that protects the
ulcer from painful stimulation by
chewing, speaking, food or drink.
STATUS
Approved in the EU, US and
other territories.
PROGRESS
Currently sold in 32 countries:
rinse = 32 countries
gel = 29 countries
spray = 21 countries.
Filed in China (Registration
process underway).
Market leader in Italy (all three
presentations) and Israel (gel).
The Aloclair® brand was reclassified
to Aloclair® Plus during March and
June 2008.
SST® AND SALINUM®
(rinse, toothpaste, gel, spray)
PRODUCT DESCRIPTION
Treats xerostomia, a dry mouth
condition, by increasing saliva
flow and lubricating the mouth.
STATUS
Approved in the EU and US and
other territories.
PROGRESS
New agreements were signed
in Greece and Taiwan.
Launches took place in the
Baltics (Latvia, Lithuania, Estonia).
